The interaction of innate immune and adaptive immune system
Ruyuan Wang,
No information about this author
Caini Lan,
No information about this author
Kamel Benlagha
No information about this author
et al.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(10)
Published: Sept. 15, 2024
The
innate
immune
system
serves
as
the
body's
first
line
of
defense,
utilizing
pattern
recognition
receptors
like
Toll-like
to
detect
pathogens
and
initiate
rapid
response
mechanisms.
Following
this
initial
response,
adaptive
immunity
provides
highly
specific
sustained
killing
via
B
cells,
T
antibodies.
Traditionally,
it
has
been
assumed
that
activates
immunity;
however,
recent
studies
have
revealed
more
complex
interactions.
This
review
a
detailed
dissection
composition
function
systems,
emphasizing
their
synergistic
roles
in
physiological
pathological
contexts,
providing
new
insights
into
link
between
these
two
forms
immunity.
Precise
regulation
both
systems
at
same
time
is
beneficial
fight
against
immune-related
diseases,
for
example,
cGAS-STING
pathway
found
play
an
important
role
infections
cancers.
In
addition,
paper
summarizes
challenges
future
directions
field
immunity,
including
latest
single-cell
sequencing
technologies,
CAR-T
cell
therapy,
checkpoint
inhibitors.
By
summarizing
developments,
aims
enhance
our
understanding
complexity
interactions
perspectives
system.
Language: Английский
The relationship between vaccination and uveitis: A comprehensive review of immune response, risk assessment, and clinical implications
Eye & ENT Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 16, 2025
Abstract
Uveitis,
an
intraocular
inflammatory
condition,
can
lead
to
significant
visual
impairment
and
is
often
associated
with
abnormal
immune
system
activation.
While
vaccination
stands
as
a
pivotal
defense
against
numerous
infectious
diseases,
its
safety
effectiveness
in
individuals
uveitis
have
come
under
heightened
scrutiny.
This
concern
arises
from
the
potential
impact
of
both
disease
itself
immunosuppressive
treatments
on
function.
Several
studies
drawn
connections
between
various
vaccines
onset
uveitis,
particularly
hepatitis
B,
human
papillomavirus,
influenza
vaccines.
Furthermore,
though
exceedingly
rare,
instances
following
COVID‐19
been
documented,
adding
another
layer
complexity.
review
delves
into
intricate
relationship
assesses
risks
for
those
afflicted,
explores
underlying
mechanisms
behind
vaccine‐induced
uveitis.
Finally,
it
offers
recommendations
patients
emphasizes
imperative
further
investigation
unravel
complex
dynamics
ultimately
informing
clinical
practice.
Language: Английский
The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
Human Vaccines & Immunotherapeutics,
Journal Year:
2025,
Volume and Issue:
21(1)
Published: Jan. 3, 2025
One
of
the
key
features
chronic
hepatitis
B
virus
(HBV)
infection
is
inability
to
mount
sufficient
and
coordinated
adaptive
immune
responses
against
HBV.
Recent
studies
on
HBV-specific
cells
antibody
surface
antigen
(anti-HBs)
have
shed
light
their
role
in
pathogenesis
(CHB).
Anti-HBs
recognized
as
a
protective
marker,
both
for
HBV
clearance
following
vaccination,
it
also
considered
an
important
indicator
functional
cure
CHB.
Notably,
impairment
may
be
reversible.
The
restoration
cell
function,
along
with
induction
anti-HBs
response,
regarded
pivotal
terminating
achieving
cure.
This
article
reviews
significance
HBV,
discusses
potential
neutralizing
antibodies
therapeutic
vaccines
promising
future
strategies.
Language: Английский
Deciphering the Complexities of Adult Human Steady State and Stress-Induced Hematopoiesis: Progress and Challenges
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 671 - 671
Published: Jan. 14, 2025
Human
hematopoietic
stem
cells
(HSCs)
have
traditionally
been
viewed
as
self-renewing,
multipotent
with
enormous
potential
in
sustaining
essential
steady
state
blood
and
immune
cell
production
throughout
life.
Indeed,
around
86%
(1011-1012)
of
new
generated
daily
a
healthy
young
human
adult
are
origin.
Therapeutically,
HSCs
contributed
to
over
1.5
million
transplants
(HCTs)
globally,
making
this
the
most
successful
regenerative
therapy
date.
We
will
commence
review
by
briefly
highlighting
selected
key
achievements
(from
1868
end
20th
century)
that
accomplishment.
Much
our
knowledge
hematopoiesis
is
based
on
small
animal
models
that,
despite
their
importance,
do
not
always
recapitulate
hematopoiesis.
Given
this,
we
critically
progress
challenges
faced
identifying
tracing
lineage
differentiation
trajectories,
referring
murine
studies
needed.
Moving
forward
given
dynamic
can
readily
adjust
variety
stressors,
then
discuss
recent
research
advances
contributing
understanding
(i)
which
HSPCs
maintain
hematopoiesis,
(ii)
where
these
located,
(iii)
mechanisms
come
into
play
when
homeostatic
switches
stress-induced
or
emergency
Language: Английский
Transformation of NETs under the effect of pathogens and IgG
А. Н. Казимирский,
No information about this author
J. M. Salmasi,
No information about this author
G. V. Poryadin
No information about this author
et al.
Bulletin of Siberian Medicine,
Journal Year:
2025,
Volume and Issue:
23(4), P. 22 - 30
Published: Jan. 18, 2025
Background
.
Many
studies
have
shown
that
neutrophil
extracellular
traps
(NETs)
in
the
form
of
web-like
structures
are
present
peripheral
blood
patients
with
inflammatory
diseases.
In
our
research,
addition
to
traditional
NET
structures,
several
anomalous
forms
were
identified,
including
NETs
cloud-like
appearance.
Aim
To
investigate
morphological
and
functional
transformation
under
influence
Klebsiella
pneumoniae
immunoglobulin
G
(IgG).
Materials
methods
The
study
included
42
Moscow
City
Clinical
Hospital
No.
51:
28
acute
inflammation
abdominal
cavity
(appendicitis,
cholecystitis,
pancreatitis,
peritonitis),
6
diagnosed
ulcerative
colitis,
8
hernias.
Neutrophils
isolated
using
gradient-density
centrifugation.
calculate
NETs,
we
used
SYBR
Green
I-induced
fluorescence
microscopy
(Evrogen,
Russia),
dye
specifically
interacting
double-stranded
DNA.
activity
was
determined
(ATCC
700603)
capture
test.
Results
diseases
postoperative
period,
times
lower
than
healthy
individuals.
these
bind
no
more
20
cells
microorganism.
Under
effect
IgG,
networks
transform
into
loose
which
can
hardly
pathogen,
binding
only
8.46
±
0.44
Spontaneous
enzymatic
degradation
cloud
like
may
be
accompanied
by
production
secondary
alteration
factors.
Conclusion
results
provide
grounds
for
development
new
approaches
elaborating
vaccination
regimens
immunobiologics
require
preliminary
monitoring
state
innate
immunity,
particular,
patient’s
body.
Language: Английский
Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study
Carlos Fierro,
No information about this author
Nelia Sánchez-Crespo,
No information about this author
Daniel Makrinos
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 10, 2025
Clinical
trials
do
not
typically
assess
underlying
molecular
mechanisms
of
vaccine
immunogenicity
or
reactogenicity.
We
evaluated
the
reactogenicity
and
4
mRNA
vaccines
potential
contributing
identified
shared
unique
clinical
immunologic
features.
This
ongoing,
open-label,
phase
1
trial
randomized
healthy
adults
(18-75
years)
to
receive
a
single
dose
mRNA-1273.222
(bivalent
COVID-19),
mRNA-1345
(RSV),
mRNA-1010
(influenza),
FLUAD
(active
influenza
comparator)
2
3
doses
mRNA-1647
(CMV).
The
primary
objective
was
safety
each
study
vaccine,
with
humoral
(neutralizing
antibody
[nAb]
responses)
as
secondary
objective.
interim
analysis
reports
in
all
single-dose
(mRNA-1273.222,
mRNA-1345,
mRNA-1010,
FLUAD).
Exploratory
objectives
included
antigen-specific
T-cell
responses
after
mRNA-1273.222,
soluble
mediators
inflammation
innate
immunity
following
vaccination
groups
two
mRNA-1647.
At
data
cutoff
(February
1,
2023),
302
participants
received
vaccines.
Reactogenicity
exhibited
consistent
trend
across
groups;
most
solicited
local
systemic
adverse
reactions
within
7
days
were
mild
moderate
severity.
There
no
deaths
serious,
severe,
treatment-related
events
leading
discontinuation.
Day
29,
nAb
titers
against
vaccine-specific
antigens
increased
2-
8-fold
versus
baseline
for
groups.
In
an
exploratory
analysis,
induced
Th1-biased
CD4+
CD8+
at
29.
cytokine
response
showed
levels
IFN-γ,
IL-6,
IL-2Ra,
CXCL9,
IP-10,
MCP-2,
MIP-1β
on
vaccination,
generally
greater
increases
observed
FLUAD.
Regardless
age
groups,
peak
serum
IL-1Ra
MCP-1/MCP-2
weakly
correlated
scores
(correlation
coefficient
range:
0.15-0.27).
had
acceptable
reactogenicity,
demonstrated
changes
biomarkers
immune
activation,
immunogenic.
suggests
that
may
be
related
features
platform
(LNP
platform).
ClinicalTrials.gov,
identifier
NCT05397223.
Language: Английский
Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(6), P. 583 - 583
Published: May 27, 2024
Animal-based
tests
are
used
for
the
control
of
vaccine
quality.
However,
because
highly
purified
and
safe
vaccines
now
available,
alternative
approaches
that
can
replace
or
reduce
animal
use
assessment
outcomes
must
be
established.
In
vitro
quality
exist
have
already
been
implemented.
these
specifically
designed
some
next-generation
vaccines,
this
makes
them
not
readily
available
testing
other
vaccines.
Therefore,
universal
non-animal
still
needed.
Specific
signatures
innate
immune
response
could
represent
a
promising
approach
to
predict
outcome
by
methods.
Type
I
interferons
(IFNs)
multiple
immunomodulatory
activities,
which
exerted
through
effectors
called
interferon
stimulated
genes
(ISGs),
one
most
important
might
provide
potential
candidate
molecular
biomarkers
purpose.
This
paper
will
mainly
examine
if
idea
feasible
analyzing
all
relevant
published
studies
provided
type
IFN-related
evaluating
safety
efficacy
profiles
using
an
advanced
transcriptomic
as
Results
revealed
such
potentially
predictive
after
addressing
limitations.
Language: Английский
Editorial to special issue “The power of immunoprofiling supported by computational data integration and machine learning”
Human Vaccines & Immunotherapeutics,
Journal Year:
2024,
Volume and Issue:
20(1)
Published: March 15, 2024
Language: Английский
Cell-free immuno-profiling on a genetically programmed biochip
Aurore Dupin,
No information about this author
Ohad Vonshak,
No information about this author
Valerie Arad
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 9, 2024
Abstract
Emerging
cell-free
synthetic
biology
approaches
provide
biosafe,
cheap,
and
versatile
genetic
tools
to
advance
therapeutic
research
development.
Combined
with
micro-fabrication
technology,
we
developed
a
platform
quantitatively
reconstitute
interactions
of
synthesized
antigens
antibodies
human
receptors
in
miniaturized
compartments
on
silicon
chip.
Photolithographic
surface
patterning
protein
traps
chip
expression
from
high
density
gene
brushes
generated
continuous
gradient
fluorescently
labeled
antigens.
Antibodies
binding
the
antigen
generate
full
curve
each
single
compartment
for
affinity
determination.
We
used
SARS-CoV-2
as
model
profile
specificity
monoclonal
>
30
viral
epitopes
simultaneously
one
genotype-phenotype
linked
compartments.
further
profiled
polyclonal
minute
volumes
sera,
revealing
patient-specific
epitope
profiles
that
are
difficult
detect
by
conventional
approaches.
Cell-free
co-synthesis
ACE2
receptor
Receptor-Binding-Domain
yielded
relative
affinities
different
variants.
This
rapid,
quantitative,
on-chip
genetically
programmed
approach
allows
study
complex
protein-protein
independent
purification
steps
immuno-profiling
fast
response
time
combating
emerging
pathogens.
Language: Английский